Inroads made on curing hepatitis C patients, but inadequate funding remains an issue

+Print Archive
2019: Hotspots

Inroads made on curing hepatitis C patients, but inadequate funding remains an issue

Hepatitis C virus
In New Zealand, patients with hepatitis C typically contract the life-threatening virus through intravenous drug use or from dirty tattoo needles
GPs are feeling good about the success of Maviret for hepatitis C patients, but still find they’re not funded enough to do the work required. Ten